Earth Science Tech (ETST) Liabilities and Shareholders Equity (2012 - 2026)
Earth Science Tech (ETST) posted Liabilities and Shareholders Equity of $9.0 million for Q1 2026, up 10.88% on a QoQ basis from $8.1 million in Q4 2025, and up 26.92% year-over-year from $7.1 million in Q1 2025.
Earth Science Tech (ETST) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends
Earth Science Tech's Liabilities and Shareholders Equity history runs 13 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 26.92% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.5 million (up 48.28% YoY) and the FY2026 annual result came in at $9.0 million, up 26.92% from the prior year.
- Liabilities and Shareholders Equity was $9.0 million for Q1 2026 at Earth Science Tech, up from $8.1 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $9.0 million in Q1 2026 and bottomed at $76942.0 in Q1 2022.
- A 5-year average of $4.3 million and a median of $3.9 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity gained 19.17% — and 2023, when it soared 3445.49%.
- Earth Science Tech's Liabilities and Shareholders Equity stood at $537376.0 in 2022, then soared by 511.1% to $3.3 million in 2023, then surged by 73.82% to $5.7 million in 2024, then surged by 41.72% to $8.1 million in 2025, then climbed by 10.88% to $9.0 million in 2026.
- Business Quant data shows ETST's Liabilities and Shareholders Equity at $9.0 million in Q1 2026, $8.1 million in Q4 2025, and $8.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn | 8.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.97 Mn |
| Dec 31, 2025 | 8.09 Mn |
| Sep 30, 2025 | 8.67 Mn |
| Jun 30, 2025 | 7.78 Mn |
| Mar 31, 2025 | 7.07 Mn |
| Dec 31, 2024 | 5.71 Mn |
| Sep 30, 2024 | 5.05 Mn |
| Jun 30, 2024 | 4.77 Mn |
| Mar 31, 2024 | 3.88 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Sep 30, 2023 | 3.08 Mn |
| Jun 30, 2023 | 2.95 Mn |
| Mar 31, 2023 | 2.73 Mn |
| Dec 31, 2022 | 537,376.00 |
| Sep 30, 2022 | 355,762.00 |
| Jun 30, 2022 | 320,323.00 |
| Mar 31, 2022 | 76,942.00 |
| Dec 31, 2021 | 25,680.00 |
| Sep 30, 2021 | 53,525.00 |
| Jun 30, 2021 | 38,998.00 |